Selection of patients with Tourette syndrome for deep brain stimulation surgery

Mauro Porta, Andrea E. Cavanna, Edvin Zekaj, Francesca D'Adda, Domenico Servello

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Deep brain stimulation (DBS) is an emerging therapeutic option for severe resistant Tourette syndrome (TS). To date, about 100~cases have been reported in the scientific literature. Different clinical guidelines have been proposed for this procedure from both USA and European centres. A number of issues remain unresolved, mainly in relation to eligibility criteria of patients with TS. We highlight the need for a comprehensive assessment of associated co-morbidities, which are not considered integral part of the syndrome and are not sufficiently evaluated in relation to DBS. The concept of refractoriness, the minimum age of candidates, and the optimal targets for DBS are also controversial.

Original languageEnglish
Pages (from-to)125-131
Number of pages7
JournalBehavioural Neurology
Volume27
Issue number1
DOIs
Publication statusPublished - 2013

Fingerprint

Tourette Syndrome
Deep Brain Stimulation
Patient Selection
Literature
Guidelines
Morbidity
Therapeutics

Keywords

  • co-morbidities
  • Deep brain stimulation
  • selection criteria
  • tics
  • Tourette syndrome

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Clinical Neurology
  • Neurology

Cite this

Selection of patients with Tourette syndrome for deep brain stimulation surgery. / Porta, Mauro; Cavanna, Andrea E.; Zekaj, Edvin; D'Adda, Francesca; Servello, Domenico.

In: Behavioural Neurology, Vol. 27, No. 1, 2013, p. 125-131.

Research output: Contribution to journalArticle

Porta, Mauro ; Cavanna, Andrea E. ; Zekaj, Edvin ; D'Adda, Francesca ; Servello, Domenico. / Selection of patients with Tourette syndrome for deep brain stimulation surgery. In: Behavioural Neurology. 2013 ; Vol. 27, No. 1. pp. 125-131.
@article{259faf3e7f9d489987849eaeb99e0bfa,
title = "Selection of patients with Tourette syndrome for deep brain stimulation surgery",
abstract = "Deep brain stimulation (DBS) is an emerging therapeutic option for severe resistant Tourette syndrome (TS). To date, about 100~cases have been reported in the scientific literature. Different clinical guidelines have been proposed for this procedure from both USA and European centres. A number of issues remain unresolved, mainly in relation to eligibility criteria of patients with TS. We highlight the need for a comprehensive assessment of associated co-morbidities, which are not considered integral part of the syndrome and are not sufficiently evaluated in relation to DBS. The concept of refractoriness, the minimum age of candidates, and the optimal targets for DBS are also controversial.",
keywords = "co-morbidities, Deep brain stimulation, selection criteria, tics, Tourette syndrome",
author = "Mauro Porta and Cavanna, {Andrea E.} and Edvin Zekaj and Francesca D'Adda and Domenico Servello",
year = "2013",
doi = "10.3233/BEN-120288",
language = "English",
volume = "27",
pages = "125--131",
journal = "Behavioural Neurology",
issn = "0953-4180",
publisher = "HINDAWI LTD",
number = "1",

}

TY - JOUR

T1 - Selection of patients with Tourette syndrome for deep brain stimulation surgery

AU - Porta, Mauro

AU - Cavanna, Andrea E.

AU - Zekaj, Edvin

AU - D'Adda, Francesca

AU - Servello, Domenico

PY - 2013

Y1 - 2013

N2 - Deep brain stimulation (DBS) is an emerging therapeutic option for severe resistant Tourette syndrome (TS). To date, about 100~cases have been reported in the scientific literature. Different clinical guidelines have been proposed for this procedure from both USA and European centres. A number of issues remain unresolved, mainly in relation to eligibility criteria of patients with TS. We highlight the need for a comprehensive assessment of associated co-morbidities, which are not considered integral part of the syndrome and are not sufficiently evaluated in relation to DBS. The concept of refractoriness, the minimum age of candidates, and the optimal targets for DBS are also controversial.

AB - Deep brain stimulation (DBS) is an emerging therapeutic option for severe resistant Tourette syndrome (TS). To date, about 100~cases have been reported in the scientific literature. Different clinical guidelines have been proposed for this procedure from both USA and European centres. A number of issues remain unresolved, mainly in relation to eligibility criteria of patients with TS. We highlight the need for a comprehensive assessment of associated co-morbidities, which are not considered integral part of the syndrome and are not sufficiently evaluated in relation to DBS. The concept of refractoriness, the minimum age of candidates, and the optimal targets for DBS are also controversial.

KW - co-morbidities

KW - Deep brain stimulation

KW - selection criteria

KW - tics

KW - Tourette syndrome

UR - http://www.scopus.com/inward/record.url?scp=84876910002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876910002&partnerID=8YFLogxK

U2 - 10.3233/BEN-120288

DO - 10.3233/BEN-120288

M3 - Article

C2 - 23187143

AN - SCOPUS:84876910002

VL - 27

SP - 125

EP - 131

JO - Behavioural Neurology

JF - Behavioural Neurology

SN - 0953-4180

IS - 1

ER -